Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a clinical trial in patients with advanced hepatocellular carcinoma (HCC) and Child-Pugh Class B7 (CPB7) cirrhosis whose disease has progressed on at least 1st-line therapy. The trial will evaluate the efficacy and safety of namodenoson as compared to placebo.
Epistemonikos ID: d179abb57032fc0e4d0ab5010017d8c8e7d2e931
First added on: May 10, 2024